Global

June 14, 2010.

Tell us and win an iPod Touch!

June 4, 2010.

It is now the job of the pharma marketer to get people talking and to listen to what they are saying. Jody Ball offers advice on making that transition.

May 24, 2010.

May 24, 2010.

May 7, 2010.

May 7, 2010.

The three-way race for control of Parliament leaves the future of the British pharmaceutical industry in the balance.

April 29, 2010.

April 21, 2010.

April 21, 2010.

April 13, 2010.

In 1995, pharmaceutical regulation in Europe underwent a dramatic change with the emergence of the European Medicines Agency. The agency's 15-year history has been eventful, with it having to adapt to a changing regulatory landscape and new expectations from those relying on it for guidance.

March 25, 2010.

The spiralling nature of disclosure in the US provides a cautionary tale for European pharma executives. Jacky Law reports.

Harold Hambrose explains why applying user-centric design to healthcare business systems can save money and lives.

March 24, 2010.

Proving that one good turn deserves another, Pfizer and GlaxoSmithKline announced that they would provide millions of doses of pneumonia vaccines to some of the world's most impoverished countries at massive discounts.

A new report from IMS Health bumps the number of emerging markets to 17 and predicts that these nations will account for $90 billion in sales in the next four years. How will pharma take advantage of the opportunity?

March 17, 2010.

Open innovation is sometimes chaotic and often difficult to measure, but getting it right can give firms a real edge now and in the future.

Having a 'maverick' in your company can lead to problems as well as breakthroughs and innovations. Judith Germain outlines the value of harnessing a brilliant but wayward talent.

4 March, 2010

Can the combination with Schering-Plough transform the company from an also-ran to a contender in the big push for market share in the developing world?